Butera, A.; Pascadopoli, M.; Gallo, S.; Pérez-Albacete MartÃnez, C.; Maté Sánchez de Val, J.E.; Parisi, L.; Gariboldi, A.; Scribante, A.
Ozonized Hydrogels vs. 1% Chlorhexidine Gel for the Clinical and Domiciliary Management of Peri-Implant Mucositis: A Randomized Clinical Trial. J. Clin. Med. 2023, 12, 1464.
https://doi.org/10.3390/jcm12041464
AMA Style
Butera A, Pascadopoli M, Gallo S, Pérez-Albacete MartÃnez C, Maté Sánchez de Val JE, Parisi L, Gariboldi A, Scribante A.
Ozonized Hydrogels vs. 1% Chlorhexidine Gel for the Clinical and Domiciliary Management of Peri-Implant Mucositis: A Randomized Clinical Trial. Journal of Clinical Medicine. 2023; 12(4):1464.
https://doi.org/10.3390/jcm12041464
Chicago/Turabian Style
Butera, Andrea, Maurizio Pascadopoli, Simone Gallo, Carlos Pérez-Albacete MartÃnez, José Eduardo Maté Sánchez de Val, Luca Parisi, Alice Gariboldi, and Andrea Scribante.
2023. "Ozonized Hydrogels vs. 1% Chlorhexidine Gel for the Clinical and Domiciliary Management of Peri-Implant Mucositis: A Randomized Clinical Trial" Journal of Clinical Medicine 12, no. 4: 1464.
https://doi.org/10.3390/jcm12041464
APA Style
Butera, A., Pascadopoli, M., Gallo, S., Pérez-Albacete MartÃnez, C., Maté Sánchez de Val, J. E., Parisi, L., Gariboldi, A., & Scribante, A.
(2023). Ozonized Hydrogels vs. 1% Chlorhexidine Gel for the Clinical and Domiciliary Management of Peri-Implant Mucositis: A Randomized Clinical Trial. Journal of Clinical Medicine, 12(4), 1464.
https://doi.org/10.3390/jcm12041464